primary dysmenorrhea. Primary dysmenorrhea
Conditions
Interventions
Intervention 1: Intervention group: 35 girls living in the dormitories of Ferdowsi University, who meet the inclusion criteria, were given oral capsules containing hydroalcoholic extract of coriander
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Be single Be in the age range of 18-30 years Have regular menstrual cycles Have moderate to severe dysmenorrhea Do not have a history of pelvic and abdominal disease Do not have a history of chronic diseases Do not have a history of pain in the abdomen and back except during menstrual bleeding Do not have a history of confirmed mental illnesses Not having severe mental stress in the last 6 months Not allergic to coriander Informed consent to participate in the study
Exclusion criteria
Exclusion criteria: Unwillingness to continue cooperation The occurrence of a severe stressful event during the study period Taking contraceptives Irregular use of medicine or placebo in the amount of two consecutive doses Getting married during the study period Performing professional sports activities Taking any type of supplement and multivitamin Presence of benign breast or uterine cysts They have had a history of prostate cancer, breast cancer and ovarian cancer in their first degree relatives Use of other herbs or drugs effective on dysmenorrhea
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity and duration of pain in early painful menstruation. Timepoint: Measuring the intensity and duration of painful menstruation at the end of menstrual bleeding during two consecutive cycles and simultaneously with the start of the drug or placebo. Method of measurement: Questionnaires made by the researcher. Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| The amount of menstrual bleeding - duration of menstrual bleeding - physical symptoms associated with menstruation. Timepoint: After the end of menstrual bleeding in two consecutive cycles and at the same time as giving medicine or placebo. Method of measurement: Questionnaires made by the researcher. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZohre Shahri
Mashhad University of Medical Sciences
Outcome results
None listed